Recent federal research security initiatives have put the U.S. at risk of losing its lead in science and technology, write senior fellow Neal F. Lane, Steven Pei, and Jeremy Wu. They lay out a path toward clear, fair policy that safeguards America’s security and competitiveness while fostering a welcoming research environment for foreign talent.
As false or inaccurate information about stem cell interventions continues to circulate widely, the authors write that immediate action is needed to improve patient education and safety — and to combat misinformation more broadly.
Ten months after the pandemic began, partisan division is severely inhibiting the United States’ COVID-19 response. The health consequences of the continued political divide could not be clearer, as the pandemic has grown beyond many experts’ worst predictions.
Quianta Moore, Christopher F. KuleszaJanuary 12, 2021
An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.
Political partisanship is strongly influencing the United States’ response to Covid-19, potentially leading to a suboptimal balance between reopening the economy and protecting public health. Read more at the Baker Institute Blog.
"This pandemic and looming economic crisis will affect all of us ... The sooner we relearn how to set aside our differences and unite during this difficult moment, the stronger we will emerge from it," writes former Secretary James A. Baker, III.
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
